Becton, Dickinson and CompanyBecton, Dickinson and CompanyBecton, Dickinson and Company

Becton, Dickinson and Company

No trades
See on Supercharts
Market capitalization
‪67.94 B‬USD
‪1.48 B‬USD
‪19.37 B‬USD
‪288.48 M‬
Beta (1Y)
0.72

About Becton, Dickinson and Company

CEO
Thomas E. Polen
Website
Headquarters
Franklin Lakes
Employees (FY)
‪73 K‬
Founded
1897
ISIN
US0758871091
FIGI
BBG000BCZYD3
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BDX is 232.60 USD — it has decreased by 0.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Becton, Dickinson and Company stocks are traded under the ticker BDX.
Becton, Dickinson and Company is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Becton, Dickinson and Company has a max estimate of 315.00 USD and a min estimate of 240.00 USD.
BDX earnings for the last quarter are 3.42 USD whereas the estimation was 3.42 USD which accounts for −0.15% surprise. Estimated earnings for the next quarter are 2.40 USD. See more details about Becton, Dickinson and Company earnings.
Becton, Dickinson and Company revenue for the last quarter amounts to ‪5.09 B‬ USD despite the estimated figure of ‪5.02 B‬ USD. In the next quarter revenue is expected to reach ‪4.73 B‬ USD.
Yes, you can track Becton, Dickinson and Company financials in yearly and quarterly reports right on TradingView.
Like other stocks, BDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Becton, Dickinson and Company stock right from TradingView charts — choose your broker and connect to your account.
BDX reached its all-time high on Jul 24, 2023 with the price of 287.32 USD, and its all-time low was 1.24 USD and was reached on Aug 19, 1974.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪73.00 K‬ employees. See our rating of the largest employees — is Becton, Dickinson and Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Becton, Dickinson and Company EBITDA is ‪4.46 B‬ USD, and current EBITDA margin is 22.49%. See more stats in Becton, Dickinson and Company financial statements.